A Critical Analysis of Computed Tomography Washout in Lipid-Poor Adrenal Incidentalomas
- PMID: 33210268
- DOI: 10.1245/s10434-020-09329-1
A Critical Analysis of Computed Tomography Washout in Lipid-Poor Adrenal Incidentalomas
Abstract
Background: Contrast-enhanced computed tomography (CT) with washout has emerged as an option to distinguish lipid-poor adenomas from non-adenomas.
Objective: The aim of this study was to assess the utility of CT washout in characterizing indeterminate lipid-poor adrenal incidentalomas.
Methods: From an Institutional Review Board-approved database, patients with adrenal incidentalomas who had adrenal protocol CT scans with a 15-min washout between 2003 and 2019 were identified. Non-contrast CT attenuation and washout patterns of different tumor types were compared.
Results: Overall, 156 patients with 175 adrenal lesions were included. Average tumor size was 3.0 cm, non-contrast CT density was 24.7 Hounsfield units (HU), and absolute washout was 52.6%. In 102 lesions (58.3%), CT washout was ≥ 60%; 94 (92.2%) of these were benign adrenocortical adenomas, 7 (6.9%) were pheochromocytomas, and 1 (0.9%) was an adrenal hematoma. Furthermore, in 73 tumors (41.7%), CT washout was < 60%; diagnosis was benign adrenocortical adenoma in 45 (61.6%) lesions, pheochromocytoma in 8 (11%) lesions, metastasis in 9 (12.3%) lesions, adrenocortical cancer in 6 (8.2%) lesions, and 'others' in 5 (6.9%) lesions. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of > 60% absolute CT washout for detecting an adrenal adenoma was 67.6%, 77.8%, 92.2%, 38.4%, and 69.7%, respectively.
Conclusion: CT washout should be incorporated into the management algorithm of indeterminate adrenal incidentalomas with a high non-contrast CT attenuation to 'rule-in' benign tumors. For small tumors with mild elevation of plasma metanephrines, it should be kept in mind that adenomas and pheochromocytomas may have similar imaging and washout characteristics.
Similar articles
-
Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.Radiology. 2005 Feb;234(2):479-85. doi: 10.1148/radiol.2342031876. Radiology. 2005. PMID: 15671003
-
Adrenal Adenoma and Pheochromocytoma: Comparison of Multidetector CT Venous Enhancement Levels and Washout Characteristics.J Comput Assist Tomogr. 2016 Mar-Apr;40(2):194-200. doi: 10.1097/RCT.0000000000000343. J Comput Assist Tomogr. 2016. PMID: 26978001
-
Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?AJR Am J Roentgenol. 2013 Jul;201(1):122-7. doi: 10.2214/AJR.12.9620. AJR Am J Roentgenol. 2013. PMID: 23789665
-
[CT and MRI in the differential diagnosis of lesions of the adrenal gland].Med Klin (Munich). 2004 Aug 15;99(8):447-52. doi: 10.1007/s00063-004-1054-1. Med Klin (Munich). 2004. PMID: 15309273 Review. German.
-
[Characterization of adrenal incidentaloma discovered with tomography. General review].Ann Urol (Paris). 2003 Oct;37(5):244-7. doi: 10.1016/s0003-4401(03)00034-2. Ann Urol (Paris). 2003. PMID: 14606311 Review. French.
Cited by
-
18F-FDG-PET/CT-based machine learning model evaluates indeterminate adrenal nodules in patients with extra-adrenal malignancies.World J Surg Oncol. 2023 Sep 26;21(1):305. doi: 10.1186/s12957-023-03184-6. World J Surg Oncol. 2023. PMID: 37749562 Free PMC article.
-
Canadian Urological Association guideline: Diagnosis, management, and followup of the incidentally discovered adrenal mass.Can Urol Assoc J. 2023 Feb;17(2):12-24. doi: 10.5489/cuaj.8248. Can Urol Assoc J. 2023. PMID: 36849113 Free PMC article. No abstract available.
-
Machine learning for differentiation of lipid-poor adrenal adenoma and subclinical pheochromocytoma based on multiphase CT imaging radiomics.BMC Med Imaging. 2023 Oct 16;23(1):159. doi: 10.1186/s12880-023-01106-2. BMC Med Imaging. 2023. PMID: 37845636 Free PMC article.
-
Oncocytic adrenocortical tumour presenting as an incidentaloma: a diagnostic challenge.BMJ Case Rep. 2022 Sep 15;15(9):e250900. doi: 10.1136/bcr-2022-250900. BMJ Case Rep. 2022. PMID: 36109089 Free PMC article.
-
Computed Tomography-Based Machine Learning Differentiates Adrenal Pheochromocytoma From Lipid-Poor Adenoma.Front Endocrinol (Lausanne). 2022 Mar 21;13:833413. doi: 10.3389/fendo.2022.833413. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35388295 Free PMC article.
References
-
- Glazer DI, Mayo-Smith WW. Management of incidental adrenal masses: an update. Abdom Radiol (NY). 2020;45(4):892–900. - DOI
-
- Fassnacht M, Arlt W, Bancos I, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016;175(2):G1-g34. - DOI
-
- OECD. Health at a Glance 2019: OECD Indicators. Paris: OECD Publishing; 2019. Available at: https://doi.org/10.1787/4dd50c09-en .
-
- Grossman A, Koren R, Tirosh A, et al. Prevalence and clinical characteristics of adrenal incidentalomas in potential kidney donors. Endocr Res. 2016;41(2):98–102. - DOI
-
- Birsen O, Akyuz M, Dural C, et al. A new risk stratification algorithm for the management of patients with adrenal incidentalomas. Surgery. 2014;156(4):959–965. - DOI
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical